Chemoprevention of HCC With Statins, Aspirin and Metformin Chemoprevention of HCC With Statins, Aspirin and Metformin
A new meta-analysis examines the question of whether statins, aspirin and metformin are chemoprotective against the development of hepatocellular carcinoma.Alimentary Pharmacology & Therapeutics
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Aspirin | Cancer & Oncology | Carcinoma | Cholesterol | Drugs & Pharmacology | Fortamet | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Metformin | Statin Therapy | Surgery